Surgeon age in relation to patients’ long-term survival after gastrectomy for gastric adenocarcinoma: nationwide population-based cohort study
BJS Open · 2024
DOI: 10.1093/bjsopen/zrae015 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift BJS Open, 2024. Verfasst von Wilhelm Leijonmarck und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine and Surgery, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden. Hauptthemen laut MEDLINE: Stomach Neoplasms, Gastrectomy, Adenocarcinoma, Surgeons. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, Swedish Cancer Society, Stockholm Cancer Society.
Abstract (Originalsprache)
Background
Increasing surgeon age may influence patient outcomes after complex procedures due to gained experience but also decreased technical and cognitive abilities. This study aimed to clarify whether surgeon age influences patients’ long-term survival after gastrectomy for gastric adenocarcinoma.
Methods
Population-based cohort study including all patients who underwent open and curatively intended gastrectomy for gastric adenocarcinoma between 2006 and 2015 in Sweden, with follow-up throughout 2020. Surgeon age, categorized into three equal-sized groups (tertiles), was assessed in relation to 5-year all-cause mortality rate (main outcome) and 5-year disease-specific death (secondary outcome) using multivariable Cox regression adjusted for patient age, sex, education, co-morbidity, pathological tumour stage, tumour sublocation and neoadjuvant therapy. Lymph node yield, resection margin status, in-hospital complications and annual surgeon volume of gastrectomy were considered potential mediators.
Results
Among 1647 patients, the 5-year all-cause mortality rate was increased for surgeon age ≥55 years (adjusted HR 1.21, 95% c.i. 1.04 to 1.41) and borderline elevated for age 47–54 years (HR 1.16, 95% c.i. 0.99 to 1.36), compared with age ≤46 years. Five-year disease-specific death was increased for surgeon age ≥55 years (HR 1.25, 95% c.i. 1.06 to 1.48) and 47–54 years (HR 1.22, 95% c.i. 1.02 to 1.44), compared with age ≤46 years. The associations attenuated and became statistically non-significant after adjustment for lymph node yield, resection margin status and complications.
Conclusion
Surgeon age ≥47 years might be associated with worse long-term survival in patients who undergo gastrectomy for gastric adenocarcinoma, possibly mediated in part by differences in lymph node yield, resection margin status and complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Molecular Medicine and Surgery, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
- Nuffield Department of Surgery, University of Oxford, Oxford, UK.
- School of Cancer and Pharmacological Sciences, King's College London, London, UK.
ORCID-Profile: Wilhelm Leijonmarck, Jesper Lagergren
Förderung
- Swedish Research Council
- Swedish Cancer Society
- Stockholm Cancer Society
Zitieren
APA
Leijonmarck, W., Mattsson, F., Asplund, J., Markar, S., & Lagergren, J. (2024). Surgeon age in relation to patients’ long-term survival after gastrectomy for gastric adenocarcinoma: nationwide population-based cohort study. BJS Open. https://doi.org/10.1093/bjsopen/zrae015
Vancouver
Leijonmarck W, Mattsson F, Asplund J, Markar S, Lagergren J. Surgeon age in relation to patients’ long-term survival after gastrectomy for gastric adenocarcinoma: nationwide population-based cohort study. BJS Open. 2024. doi:10.1093/bjsopen/zrae015
BibTeX
@article{Leijonmarck2024,
author = {Leijonmarck, Wilhelm and Mattsson, Fredrik and Asplund, Johannes and Markar, Sheraz and Lagergren, Jesper},
title = {Surgeon age in relation to patients’ long-term survival after gastrectomy for gastric adenocarcinoma: nationwide population-based cohort study},
journal = {BJS Open},
year = {2024},
doi = {10.1093/bjsopen/zrae015}
}
EUVIMED